MXPA02007641A - Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration. - Google Patents
Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration.Info
- Publication number
- MXPA02007641A MXPA02007641A MXPA02007641A MXPA02007641A MXPA02007641A MX PA02007641 A MXPA02007641 A MX PA02007641A MX PA02007641 A MXPA02007641 A MX PA02007641A MX PA02007641 A MXPA02007641 A MX PA02007641A MX PA02007641 A MXPA02007641 A MX PA02007641A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- tinidazole
- fluconazole
- combination
- oral administration
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention refers to the use of the pharmaceutical composition of two active principles, which are fluconazole and tinidazole, completely compatible and the composition for the administration in the human body. This combination is useful to eradicate vulvo-cervico-vaginal mixed infections and presents synergy to obtain an ample action profile in the therapy of this type of infections.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA02007641A MXPA02007641A (en) | 2002-08-08 | 2002-08-08 | Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA02007641A MXPA02007641A (en) | 2002-08-08 | 2002-08-08 | Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration. |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02007641A true MXPA02007641A (en) | 2004-04-02 |
Family
ID=34432119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02007641A MXPA02007641A (en) | 2002-08-08 | 2002-08-08 | Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MXPA02007641A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005070421A1 (en) * | 2004-01-22 | 2005-08-04 | Alparis S.A. De C.V. | Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same |
WO2010026469A1 (en) * | 2008-09-04 | 2010-03-11 | Laboratorios Senosiain S.A. De C.V. | Pharmaceutical composition for use in treating sexually transmitted infections |
-
2002
- 2002-08-08 MX MXPA02007641A patent/MXPA02007641A/en active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005070421A1 (en) * | 2004-01-22 | 2005-08-04 | Alparis S.A. De C.V. | Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same |
US8309103B2 (en) | 2004-01-22 | 2012-11-13 | Alparis, S.A. De C.V. | Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
WO2010026469A1 (en) * | 2008-09-04 | 2010-03-11 | Laboratorios Senosiain S.A. De C.V. | Pharmaceutical composition for use in treating sexually transmitted infections |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062504L (en) | Compositions and dosage forms for improved absorption | |
BRPI0415007A (en) | method for treating, preventing, modifying or administering pain and pharmaceutical composition | |
BRPI0416260A (en) | method for treating, preventing or controlling an asbestos-related disease or disorder and pharmaceutical composition | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
HK1100480A1 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
AR026916A1 (en) | PHARMACEUTICAL COMBINATIONS AND THEIR USE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS | |
ES2187300A1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
MXPA06013133A (en) | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction. | |
TW200603787A (en) | Topical preparations containing ambroxol | |
ATE298324T1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
MXPA05005338A (en) | Methods of administering dalbavancin for treatment of bacterial infections. | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
HUP0400553A2 (en) | Pharmaceutical compositions | |
BR0315316A (en) | Methods of treating, preventing or controlling a myelodysplastic syndrome, and reducing or preventing an adverse effect associated with the administration of a second active ingredient to a patient suffering from a myelodysplastic syndrome, pharmaceutical composition, unit dosage form, and kit | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
ATE454139T1 (en) | MEDICINAL PRODUCTS WITH SHIKONIN AS THE ACTIVE INGREDIENT | |
TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
BR0315609A (en) | Method of treating, preventing, modifying or controlling pain and pharmaceutical composition | |
TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
MXPA02007641A (en) | Pharmaceutical use of the fluconazole and tinidazole combination and its composition for oral administration. | |
CA2385755A1 (en) | Prevention of colorectal cancer | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
IL163091A (en) | Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights | ||
GD | Licence granted | ||
FG | Grant or registration | ||
GD | Licence granted |